Thyroid Cancer
7 competing products in clinical development for Thyroid Cancer.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 24
Phase 31
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Placebo + Lenvatinib | Eisai | Phase 3 | Completed | 40 |
| Irofulven + capecitabine | Eisai | Phase 2 | Completed | 35 |
| Lenvatinib + Lenvatinib matching placebo | Eisai | Phase 2 | Completed | 35 |
| E7080 capsule | Eisai | Phase 2 | Completed | 35 |
| Lenvatinib (DTC Cohort) + Lenvatinib (MTC Cohort) | Eisai | Phase 2 | Completed | 35 |
| Bexarotene | Eisai | Phase 1 | Completed | 29 |
| Lenvatinib | Eisai | Pre-clinical | Completed | 26 |